For some people battling major depression, a new medical treatment that sends magnetic pulses into the brain has been found to be effective. Studies also show that care can be effective in reducing migraine headaches and helping stroke victims regain mobility and motor skills. Learn more about FLORIDA TMS CLINIC.
Treatment through Transcranial Magnetic Stimulation (TMS) utilizes magnetic pulses to activate the nerve cells in the brain. It is a non-invasive ambulatory procedure, indicating that in a hospital, it does not require medication, chemotherapy or healing period. Past findings found that people using TMS treatment saw a 50 per cent decrease in symptoms of depression.
Federal Drug Administration ( FDA) recommends TMS treatment for use in adult patients who have sought psychiatric medicine but have not had any improvement. TMS care is only accessible in the nation from a few limited facilities, and is not even widely provided by health insurance policies.
How Does TMS Function
TMS treatment is performed by gently pressing a medication coil on a patient’s scalp as they rest in a reclining position. The coil then directly emits magnetic fields to the portion of the brain involved in mood regulation. The magnetic fields contain the low electric currents. The currents change cell activity in the brain which is known to be effective in reducing symptoms of depression.
Treatment lasts approximately 40 minutes a hour, with patients fully awake throughout the process. Typically, patients are given five weekly treatments over a six week period. During clinical trials the most frequent side effect correlated with therapy was scalp pain or irritation-usually mild to moderate.
Studies also shown that most patients respond better to 40 consecutive magnetic pulses stimulation of the brain twice a minute for a four second duration. Nonetheless, length, size, and amount of pulses obtained each session depend on how the patient reacts to the medication being administered by the doctor.
Lower rates of relapsing depression
Two new findings show people with severe depression were less prone to rebound following diagnosis with TMS due to opioid or electroconvulsive therapy (ECT).
The study showed just 10 to 12 percent of patients whose disorder originally fell into remission after a reversal in TMS therapy. The TMS findings in a strong comparison to the relapse incidence of 40 percent encountered by people experiencing recovery in an anti-depression drug trial, a figure close to those reported by ECT users.
At the conference of the American Psychiatric Association this year, the two separately published TMS experiments were presented. Both studies were open to patients who had failed antidepressant therapies before.